ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo

References

• StebbingJJonesABarrett-LeePCardiotoxicity and anthracyclinesBreast Cancer Res Treat2008107345145318167621
   PubMed Web of Science ®Google Scholar
• OctaviaYTocchettiCGGabrielsonKLJanssensSCrijnsHJMoensALDoxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesJ Mol Cell Cardiol20125261213122522465037
   PubMed Web of Science ®Google Scholar
• TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol201365215717023278683
   PubMed Web of Science ®Google Scholar
• ParkHTsutsumiHMiharaHCell-selective intracellular drug delivery using doxorubicin and α-helical peptides conjugated to gold nanoparticlesBiomaterials201435103480348724439396
   PubMed Web of Science ®Google Scholar
• El-SheikhAAMorsyMAMahmoudMMRifaaiRAProtective mechanisms of coenzyme-Q10 may involve up-regulation of testicular P-glycoprotein in doxorubicin-induced toxicityEnviron Toxicol Pharmacol201437277278124632013
   PubMed Web of Science ®Google Scholar
• CaoSDurraniFATóthKRustumYMSe-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal modelsBr J Cancer201411071733174324619073
   PubMed Web of Science ®Google Scholar
• TortorellaSKaragiannisTCTransferrin receptor-mediated endocytosis: a useful target for cancer therapyJ Membr Biol2014247429130724573305
   PubMed Web of Science ®Google Scholar
• Rosas-GarcíaVMAlfaro-LópezTComputational study on the dimerization of indoloquinolizinesJ Mol Struct Theochem2005719225228
   Google Scholar
• LiSWangYWangFPZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosisInt J Nanomed20151052735292
   PubMed Web of Science ®Google Scholar
• ZhaoMWangCGuoMSynthesis of 6-amino acid substituted 4,6,7, 12-tetrahydro-4-oxoindolo[2,3-a]quinolizinesJ Prakt Chem19993417691694
   Google Scholar
• Solis-MaldonadoCQuintanilla-LiceaRTamez-GuerraRRodríguez-PadillaCGomez-FloresRDifferential effects of synthetic indoloquinolizines on in vitro rat lymphocyte and macrophage functionsInt Immunopharmacol2003391261127112890424
   PubMedGoogle Scholar
• MallickAHaldarBSenguptaS7-Hydroxy-4-methyl-8-(4′-methylpipera-zine-1′-yl)methyl coumarin: an efficient probe for fluorescence resonance energy transfer to a bioactive indoloquinolizine systemJ Lumin20061182165172
   Google Scholar
• SankarMGMantilliLBullJStereoselective synthesis of a natural product inspired tetrahydroindolo[2,3-a]quinolizine compound libraryBioorg Med Chem201523112614262025648684
   PubMedGoogle Scholar
• WojcieszakRCuccoviaIMSilvaMASelective oxidation of glucose to glucuronic acid by cesium-promoted gold nanoparticle catalystJ Mol Catal A Chem20164223542
   Google Scholar
• LewisSSHutchinsonMRZhangYGlucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced painBrain Behav Immun201330243223348028
   PubMed Web of Science ®Google Scholar
• ZhangRChenSWangXSynthesis and DNA-binding properties of novel DNA cyclo-intercalators containing purine-glucuronic acid hybridsCarbohydr Res2016429485327154614
   PubMedGoogle Scholar
• Sánchez LafargaAKPacheco MoisésFPGurinovAOrtizGGCarbajal ArízagaGGDual responsive dysprosium-doped hydroxyapatite particles and toxicity reduction after functionalization with folic and glucuronic acidsMater Sci Eng C201548541547
   PubMedGoogle Scholar
• AndradeGPLimaMAde SouzaAAA heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activityCarbohydr Polym201394164765423544586
   PubMedGoogle Scholar
• NelwamondoSMMMolotoMJKrauseRWDirect synthesis of water soluble CuS and CdS nanocrystals with hydrophilic glucuronic and thioglycolic acidsMater Res Bull2012471243924397
   Google Scholar
• TavanoLAielloRIoeleGNiosomes from glucuronic acid-based surfactant as new carriers for cancer therapy: preparation, characterization and biological propertiesColloids Surf B Biointerfaces201411871324709252
   PubMed Web of Science ®Google Scholar
• RofflerSRWangSMChernJWAnti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugateBiochem Pharmacol19914210206220651741786
   PubMed Web of Science ®Google Scholar
• FujitaYMieMKobatakeEConstruction of nanoscale protein particle using temperature-sensitive elastin-like peptide and polyaspartic acid chainBiomaterials200930203450345719324406
   PubMed Web of Science ®Google Scholar
• MuzzalupoRTavanoLLa MesaCAlkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological propertiesInt J Pharm2013458122422924060370
   PubMedGoogle Scholar
• BlanzatMMassipSSpezialeVFirst example of helices and tubules in aqueous solution of a new fluorescent catanionic sugar surfactantLangmuir2001171135123514
   Google Scholar
• DufesCSchätzleinAGTetleyLNiosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targetingPharm Res200017101250125811145231
   PubMed Web of Science ®Google Scholar
• ZhuHWangYZhaoMEnergy minimized crystal structures of P-selectins based on molecular dynamics simulation: leading to two average structures capable of designing anti-thrombotic agentsMedchemcomm2013410661072
   Google Scholar
• FengQZhaoMGanTDHDMIQK(KAP): a novel nano-delivery of dihydroxyltetrahydroisoquinoline-3-carboxylic acid and KPAK towards thrombusJ Mater Chem B2016459916003
   PubMedGoogle Scholar
• JinSWangYZhuHNano-sized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by a target carrier Arg-Gly-Asp-Val tetrapeptideACS Nano201377664767323931063
   PubMed Web of Science ®Google Scholar
• EgbertsJHCloostersVNoackAAnti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasisCancer Res20086851443145018316608
   PubMed Web of Science ®Google Scholar
• SugimotoMYamaokaYFurutaTInfluence of interleukin polymorphisms on development of gastric cancer and peptic ulcerWorld J Gastroenterol201016101188120020222161
   PubMed Web of Science ®Google Scholar
• ChelliahRLuckingAJTattersallLP-selectin antagonism reduces thrombus formation in humansJ Thromb Haemost20097111915191919691482
   PubMedGoogle Scholar
• KanzRVukovichTVormittagRThrombosis risk and survival in cancer patients with elevated C-reactive proteinJ Thromb Haemost201191576320874781
   PubMed Web of Science ®Google Scholar
• SallahSWanJYNguyenNPVenous thrombosis in patients with solid tumors: determination of frequency and characteristicsThromb Haemost200287457557912008937
   PubMed Web of Science ®Google Scholar
• van AkenBEReitsmaPHRosendaalFRInterleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosisBr J Haematol2002116117317711841414
   PubMed Web of Science ®Google Scholar
• WakefieldTWGreenfielLJRolfeMWInflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosisThromb Haemost19936921641728456429
   PubMed Web of Science ®Google Scholar
• FoxAEKahnSRThe relationship between inflammation and venous thrombosis. A systematic review of clinical studiesThromb Haemost200594236236516113826
   PubMed Web of Science ®Google Scholar